NEW YORK (GenomeWeb) – Continuing the climb it began in April, the GenomeWeb Index outperformed the broader stock market in May, gaining more than 7 percent.

The Index outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which gained 1 percent, 5 percent, and 5 percent, respectively. Stock performance in the May GenomeWeb Index was largely positive, as 20 of the 26 stocks saw gains and only six saw losses.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.